Communiqués SOPHiA GENETICS SA BOERSE MUENCHEN

Actions

90B

CH1125843347

Marché Fermé - BOERSE MUENCHEN Autres places de cotation 21:43:10 28/06/2024			Varia. 5j.	Varia. 1 janv.
4,24 ^EUR	-0,47%		-4,07%	-3,64%

24/06	Sophia Genetics S. A. lance une nouvelle application pour les myéloïdes aigus résiduels	CI
29/05	Mise a jour sectorielle : Les actions du secteur de la sante chutent en fin d'apres-midi	MT

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

SOPHiA GENETICS : Of SOPHiA GENETICS SA Form 6 K	25/06	PU
SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting	24/06	AQ
SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application	24/06	PR
SOPHiA GENETICS : IUCT Oncopole Becomes First French Hospital to Adopt MSK ACCESS® powered with SOPHiA DDM™	20/06	PU
SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM Platform	14/06	AQ
SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM™ Platform	13/06	PR
SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care	30/05	AQ
SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities	29/05	AQ
SOPHiA GENETICS Announces Instituto Mario Penna as New Customer	21/05	AQ
SOPHiA GENETICS Announces Instituto Mário Penna as New Customer	20/05	PR
Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS	16/05	PR
SOPHiA GENETICS Reports First Quarter 2024 Results	07/05	AQ
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference	30/04	AQ
SOPHiA GENETICS : to Present at the 2024 RBCCM Global Healthcare Conference	30/04	PU
SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024	23/04	AQ
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa	23/04	PR
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)	17/04	PR
SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership	04/04	AQ
Laboratorio Barnafi-Krause is Live on SOPHiA DDM™	02/04	PR
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada	20/03	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués SOPHiA GENETICS SA BOERSE MUENCHEN

Actions

90B

CH1125843347

Communiqués

Filtres